文章核心观点 AgEagle Aerial Systems公司宣布推出eBee VISION下一代应用软件，其具备手动位置更新等关键更新功能，能在GNSS信号不佳区域提供精确导航，还包含多项其他功能提升无人机操作性能 [1][2] 软件更新关键功能 - 手动位置更新：可通过地图参考进行手动位置更新，在GNSS信号不可用或不可靠区域提供精确导航 [1] - 光流稳定目标锁定：相机锁定兴趣点后，利用视觉线索使目标保持居中 [3] - GNSS恢复或视觉重新定位后自适应行为：无人机位置突然更新时，能智能继续当前任务或适当调整 [4] - 改进地面检测：算法改进，降低飞行中误判“着地”风险 [5] - 起飞时改进皮托管处理：在具有挑战性条件下发射更可靠，减少皮托管传感器错误 [6] - 剩余飞行时间和返航估计：提供实时任务持续时间和返航时间估计，根据实时风和功耗数据动态调整 [7] - 大风条件下优化巡航速度：根据实际风力强度调整巡航速度，提高续航能力 [8][10] - STL高度校准高精度着陆：使用LIDAR校准着陆区高度，确保准确着陆 [11] - 云台障碍物自动恢复：云台被阻挡时，新的自清理机制可在飞行中尝试恢复 [12] - 智能电机减速防过热：电机接近过热阈值时，临时降低速度防止关机 [13] 手动位置控制无GNSS的关键优势 - 操作连续性：在GPS受干扰或受阻时实现无人机不间断导航 [9] - 任务灵活性增强：支持通过视觉确认和地图实时调整无人机位置 [9] - 情景恢复能力：提高无人机在恶劣或不可预测条件下情报、监视和侦察操作的可靠性 [9] 公司简介 - 公司通过三个卓越中心，设计和交付一流飞行硬件、传感器和软件，为客户解决重要问题 [14] - 2010年成立，最初为农业行业开发固定翼无人机和基于航空影像的数据收集与分析解决方案 [14] - 如今是全球能源、建筑、农业和政府领域全栈无人机系统、传感器和软件解决方案的领先供应商 [14]

文章核心观点 - 临床阶段制药公司Plus Therapeutics宣布任命Kyle Guse为董事会成员，其将担任审计委员会主席并加入薪酬委员会，Kyle Guse丰富经验有望助力公司发展 [1][2] 公司动态 - Plus Therapeutics宣布任命Kyle Guse为董事会成员，他将担任审计委员会主席并任职于薪酬委员会 [1] 被任命人情况 - Kyle Guse有30年专业经验，曾担任Atossa Therapeutics首席财务官等职，现担任DDC Enterprise首席法律官 [2] - 他曾是国际顶级律师事务所合伙人，也曾是四大会计师事务所注册会计师，拥有圣克拉拉大学法学博士学位和加州州立大学萨克拉门托分校工商管理硕士学位 [3] 各方评价 - 公司总裁兼首席执行官Marc H. Hedrick称Kyle Guse经验将对董事会产生积极影响，有助于执行公司商业计划和提升股东价值 [2] - Kyle Guse认为公司在治疗和诊断市场有重大机会，有潜力影响市场，期待与董事会和管理层合作发挥公司潜力 [4] 公司概况 - Plus Therapeutics总部位于德克萨斯州休斯顿，是临床阶段制药公司，开发中枢神经系统难治癌症的靶向放射疗法，结合图像引导局部β辐射和靶向药物递送方法推进产品管线，通过战略伙伴关系建立供应链 [4]

文章核心观点 - 同行评审期刊NEJM Evidence发表UBX1325治疗糖尿病黄斑水肿（DME）的2期BEHOLD研究结果 ，显示选择性清除视网膜衰老细胞可改善患者视力 ，支持UBX1325作为视网膜疾病新疗法的潜力 [1] 研究情况 - BEHOLD研究是概念验证2期研究 ，多中心、随机、双盲、假手术对照 ，评估单剂10 mcg UBX1325对DME患者的安全性、耐受性、有效性和持久性 [3] - 研究招募65名患者 ，尽管接受至少6个月抗VEGF治疗 ，仍有持续视力缺陷和残余视网膜液 ，50名患者完成48周研究延长期 [3] - 公司正在进行2b期ASPIRE研究 ，评估多剂量UBX1325与阿柏西普的头对头对比 ，24周和36周的顶线数据已披露 ，完整36周数据预计在2025年第二季度公布 [2] 药物情况 - UBX1325是研究性化合物 ，用于视网膜疾病包括DME的研究 ，未在任何国家获批使用 [4] - 它是BCL - xL的小分子抑制剂 ，旨在抑制衰老细胞生存依赖的蛋白质功能 [4] - BEHOLD研究显示单剂UBX1325与假手术治疗相比 ，48周内最佳矫正视力有显著临床改善 [4] 公司情况 - 公司致力于开发延缓、阻止或逆转衰老相关疾病的新疗法 ，目前专注于选择性消除或调节衰老细胞的药物 ，用于眼科和神经疾病 [5]

DALLAS, April 23, 2025 (GLOBE NEWSWIRE) -- Westwood Holdings Group, Inc. (NYSE:WHG) will release its first quarter 2025 earnings after the close of the New York Stock Exchange on Wednesday, April 30, 2025. Following the release, the Company will host a live audio webcast and conference call at 4:30 pm Eastern Time (3:30 pm Central Time). To join the conference call, please register here: https://register-conf.media-server.com/register/BI848844d99e514a3ba97ad4fbad4288af. After registering, you will be provid ...

NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (NASDAQ:TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced it will host a conference call and live webcast at 8:30 a.m. ET on Monday, April 28, 2025, to review updated safety and efficacy data from the ongoing Phase 2 open-label ADVANCED-2 trial of TARA-002 in patients with non-muscle invasive bladder cancer (NMIBC), including data from patients who have rea ...

DALLAS, April 23, 2025 (GLOBE NEWSWIRE) -- Berry Corporation (bry) (NASDAQ:BRY) ("Berry" or the "Company") today provided an update on its hedge and liquidity position, further bolstering the Company's financial strength and visibility in the current commodity price environment. The Company raised the average hedged price in 2026 and 2027 by $6 per barrel on 2.3 MBbls/d. The Company's oil volumes are 73% hedged for the remainder of 2025 and 63% hedged for 2026, based on the midpoint of Berry's full year 202 ...

Beijing, April 23, 2025 (GLOBE NEWSWIRE) -- WiMi Developed a Quantum Computing-Based Feedforward Neural Network (QFNN) Algorithm BEIJING, Apr. 23, 2025––WiMi Hologram Cloud Inc. (NASDAQ:WIMI) ("WiMi" or the "Company"), a leading global Hologram Augmented Reality ("AR") Technology provider, announced the development of a Quantum Computing-Based Feedforward Neural Network (QFNN) algorithm aimed at overcoming computational bottlenecks in traditional neural network training. The core innovation of this algorith ...

SAN MATEO, Calif., April 23, 2025 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. ((Sagimet, NASDAQ:SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that three poster presentations featuring additional analyses from the Phase 2b FASCINATE-2 study of denifanstat in MASH will be presented at the European Association for the Study of Liver (EASL) Congress 2025 being held May 7-10, 2025 in Amsterdam, Netherlands ...

BOCA RATON, FL, April 23, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corporation (NASDAQ:JNVR) (the "Company") today announced the appointment of Fei "John" Han as Chief Financial Officer, as well as Dan Kang ("DK") as Head of Investor Relations. The new appointments underscore the Company's commitment to building a world-class financial and investor relations function as it scales its crypto-forward treasury strategy. Han brings over 15 years of experience across traditional finance and crypto, with a track ...

SHANGHAI and BURLINGTON, Mass., April 23, 2025 (GLOBE NEWSWIRE) -- Just ahead of Auto Shanghai 2025, Cerence Inc. (NASDAQ:CRNC) ("Cerence AI"), a global leader pioneering conversational AI-powered user experiences, today announced a new partnership with MediaTek and expanded collaboration with NVIDIA to deliver the next generation of CaLLM™ Edge, its embedded small language model (SLM) purpose-built for automotive user experiences. With new multi-modal capabilities powered by NVIDIA AI Enterprise software, ...